NICE has backed Emgality (galcanezumab) as a once-monthly injection to prevent migraine attacks in people with episodic or chronic migraine who suffer at least four days with a migraine headache ...
Emgality is available as a once-monthly, self-administered, subcutaneous injection, like Aimovig. Teva offers the option of a quarterly injection with Ajovy, as well as a monthly dosing schedule.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback